Awake Prone Positioning in Moderate to Severe COVID-19
Evaluation of Awake Prone Positioning Effectiveness in Moderate to Severe COVID-19
1 other identifier
interventional
93
1 country
1
Brief Summary
The purpose of this study is comparing vital signs between standard care and prone position groups. Standard care will consist of routine clinical care, including any advice to lie in prone position as routinely recommended by participating sites. For those randomized to prone position, a special intervention team will visit patients' rooms aiming for patients to maintain the prone position for at least 8 hours a day.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable covid19
Started Mar 2022
Typical duration for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2021
CompletedFirst Posted
Study publicly available on registry
October 19, 2021
CompletedStudy Start
First participant enrolled
March 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedJune 7, 2023
June 1, 2023
1.1 years
October 10, 2021
June 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of participants who require escalation of respiratory therapy
Escalation of respiratory therapy within 28 days of randomization, defined as any of the following: * Escalation to next level respiratory support (with lowest level nasal cannula or face mask, escalating through HFNC to NIV or mechanical ventilation). * Intubation
Up to 28 days after enrollment
Secondary Outcomes (4)
Fatal event
Up to 28 days after enrollment
Duration of hospital stay
Up to 2 months after enrollment
Improvement in oxygen related parameters
Up to 28 days after enrollment
Number of adverse events
Up to 28 days after enrollment
Study Arms (2)
standard care
NO INTERVENTIONStandard care will consist of routine clinical care, including any advice to lie in prone position as routinely recommended by participating sites
prone position
EXPERIMENTALprone position group will have a special intervention team who visits patients' rooms aiming for patients to maintain the prone position for at least 8 hours a day
Interventions
The team will give written and verbal advice and if necessary aid patients' positioning themselves in the prone position for at least 8 hours per day. The exact duration of prone sessions will be determined according to ward schedules to take account of nursing procedures, meal times and mitigation strategies. Other methods to encourage the maintenance of prone position includes phone calls to patients, carers or education of carers.
Eligibility Criteria
You may qualify if:
- Probable or confirmed COVID-19 infection according to WHO criteria
- Moderate or severe COVID-19 respiratory infection according to Vietnamese guidelines
- Requirement for supplemental oxygen therapy
You may not qualify if:
- Invasive mechanical ventilation, or non-invasive ventilation (NIV) with CPAP or BiPAP or imminent need for these
- Contraindications to prone position (see Appendix 5)
- Pregnancy
- Severe obesity (BMI \>35),
- Altered level of consciousness (GCS \<13)
- Attending doctor judged prone position to be unsuitable for the patient for any reason
- Patients in whom there is a decision that care will not be escalated
- Failure to have informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital for Tropical Diseases
Ho Chi Minh City, Vietnam
Related Publications (4)
Dondorp AM, Hayat M, Aryal D, Beane A, Schultz MJ. Respiratory Support in COVID-19 Patients, with a Focus on Resource-Limited Settings. Am J Trop Med Hyg. 2020 Jun;102(6):1191-1197. doi: 10.4269/ajtmh.20-0283.
PMID: 32319424BACKGROUNDGonzalez-Seguel F, Pinto-Concha JJ, Aranis N, Leppe J. Adverse Events of Prone Positioning in Mechanically Ventilated Adults With ARDS. Respir Care. 2021 Dec;66(12):1898-1911. doi: 10.4187/respcare.09194. Epub 2021 Jul 23.
PMID: 34301802BACKGROUNDEhrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E; Awake Prone Positioning Meta-Trial Group. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20.
PMID: 34425070BACKGROUNDPhong NT, Duc DH, Hai HB, Nguyen NT, Khoa LDV, Khanh LTT, Tran LHB, Linh NTM, Van CTC, Thao DP, Trinh NTD, Kieu PT, Truong NT, Hoang VT, Ngoc NT, Vien TTD, Ly VT, Khoa TD, Beane A, Anibal J; OUCRU COVID RESEACH GROUP; Thwaites GE, Geskus R, Clifton D, Dung NTP, Kestelyn E, Glover G, Tan LV, Yen LM, Tung NLN, Dung NT, Thwaites CL. Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial. Wellcome Open Res. 2024 Dec 7;9:543. doi: 10.12688/wellcomeopenres.22792.2. eCollection 2024.
PMID: 39654551DERIVED
Related Links
- Prone position in ARDS patients: why, when, how and for whom. Intensive Care Med \[Internet\]. 2020;46(12):2385-96.
- Prone positioning in severe acute respiratory distress syndrome. N Engl J Med \[Internet\]. 2013 Jun 6 \[cited 2014 May 23\];368(23):2159-68
- Vietnam Ministry of Health guideline on COVID-19 management, treatment
- Effect of awake prone position on diaphragmatic thickening fraction in patients assisted by noninvasive ventilation for hypoxemic acute respiratory failure related to novel coron
- Effect of early awake prone positioning application on prognosis in patients with acute respiratory failure due to COVID-19 pneumonia: a retrospective observational study. Brazilian J Anesthe
- Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method. Crit Care \[Internet\]
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Louise C Thwaites, MD. PhD.
University of Oxford, UK
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2021
First Posted
October 19, 2021
Study Start
March 8, 2022
Primary Completion
March 31, 2023
Study Completion
May 1, 2023
Last Updated
June 7, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
Anonymised data of this study may be requested for publication by journals. Sharing anonymised data with future similar/suitable studies will be decided by the sponsor, PIs and the authority agency where the data was collected. No identifiable information will be shared with any other person/organisation